FDA Inspections - What Regulators Expect and How to Prepare

Session 1: Introduction and Understanding the FDA Inspection Framework

• Course objectives, participant expectations, and inspection-related challenges
• FDA mission, regulatory authority, and responsibilities
• FDA inspection philosophy and regulatory expectations
• Overview of GMP requirements and applicable 21 CFR regulations
• Risk-based regulatory oversight and current FDA inspection developments

Session 2: Establishing an Effective FDA Inspection Readiness Program

• Roles of site leadership, Quality Assurance, and functional departments
• Establishing an inspection management team
• Readiness planning and internal responsibilities
• Inspection Readiness Kit and documentation preparedness
• Employee awareness, inspection training, and preparation for announced and unannounced inspections

Session 3: Managing the FDA Inspection Process

• Investigator arrival and initial interactions; understanding FDA Form 482
• Opening, daily, and closing meetings
• Managing facility tours, investigator interviews, document requests, and record retrieval
• Inspection documentation and observation tracking
• Internal communication, escalation, and managing activities through closeout

Session 4: Practical Workshop – Simulated FDA Inspection

A case study involving a pharmaceutical manufacturing facility. Participants will:

• Review inspection readiness and identify potential GMP and documentation deficiencies
• Evaluate investigator requests and inspection activities
• Discuss appropriate employee responses and interview practices
• Identify potential inspection observations and actions for managing the inspection

Session 5: Employee Responsibilities and Inspection Best Practices

• Employee roles and preparing personnel for investigator interviews
• Dos and don’ts when interacting with investigators
• Responding accurately and professionally to questions
• Handling unexpected requests and challenging situations
• Common inspection mistakes and how to avoid them

Session 6: FDA Regulations, Inspection Procedures and Compliance Expectations

• Applicable 21 CFR requirements, including Parts 210 and 211
• FDA Investigations Operations Manual and inspection procedures
• FDA Forms 482 (Notice of Inspection), 483 (Inspectional Observations), and 484 (Receipt for Samples)
• Establishment Inspection Reports (EIR) and common GMP inspection deficiencies
• Risk-based inspection approaches and current regulatory developments
• Introduction to the QMSR inspection framework for medical device manufacturers, where applicable

Session 7: Responding to FDA Inspection Findings and Regulatory Observations

• Understanding and evaluating FDA Form 483 observations
• Identifying underlying compliance gaps and systemic issues
• Developing effective and timely responses to FDA observations
• Root cause analysis, corrective action planning, CAPA, and remediation strategies
• Implementation timelines, accountability, effectiveness checks, and preventing repeat observations
• Understanding FDA Warning Letters and regulatory enforcement actions

Session 8: Inspection Communication and Common Compliance Challenges

• Effective communication with FDA investigators
• Managing interactions between inspectors and company personnel
• Coordinating communication across departments
• Handling difficult questions and unexpected requests
• Documentation, escalation, organizational readiness challenges, and continuous preparedness

Session 9: Advanced Workshop – GMP Inspection of a Pharmaceutical Manufacturing Facility

Participants apply their knowledge in a simulated pharmaceutical GMP inspection case study:

• Review the facility and operational environment
• Assess readiness and identify compliance vulnerabilities
• Review relevant GMP documentation and case details
• Determine how the FDA inspection should proceed
• Evaluate investigator requests and potential observations
• Develop inspection management, communication, corrective action, and follow-up strategies

Session 10: Lessons Learned and Sustaining Inspection Readiness

• Key lessons and best practices for successful FDA inspection management
• Maintaining a continuous state of inspection readiness
• Strengthening internal audits and compliance monitoring
• Improving management oversight and quality accountability
• Participant discussion and key takeaways